Case of São Paulo Patient Sparks Interest

Anecdotal report arouses both interest and skepticism in the scientific community and requires further study.

• Exploring Cell Proteins That Block HIV
• A Tale of Two Viruses: HIV Researcher Joins Fight Against COVID-19
• The London Patient - 30 Months Free of HIV
• amfAR Second Largest Funder of HIV Cure Research Worldwide

Assessing the Impact of Covid-19 on Black Americans

New amfAR study finds that disproportionately black counties account for 52% and 58% of COVID-19 cases and deaths, respectively.

• Know Your Status. Know Your Risk.
• Long-Acting Antiretroviral Blocks HIV
• Context Matters - Health Insurance Coverage Is Fundamental to Ending the HIV Epidemic
• Policy Responses: Parallels Between HIV and COVID-19

UNAIDS Warns 2020 Targets Out of Reach

UNAIDS report shows highly unequal progress in the global fight against AIDS.

• Global Anti-HIV Drug Supplies Running Low
• COVID-19 Pandemic Threatens HIV Drug Supplies
• Former TREAT Asia Student Researcher Named Student Who Rocked Public Health

COVID-19 and HIV/AIDS

We are constantly gathering new information to keep you up to date on the intersection between HIV and COVID-19. The hard-won lessons of HIV research are informing the race to find effective treatments and a vaccine for COVID-19.

International AIDS Conference Goes Virtual

amfAR was featured prominently at the world's largest meeting for the HIV field, which "convened" July 6-10.

A Conversation with the San Francisco Patient

Loreen Willenberg talks about her inspirational journey living with HIV from her diagnosis to participating in clinical research.

Intersections #8: HIV and COVID-19 – DNA Vaccine

amfAR-funded HIV researcher Dr. Dan Barouch of Harvard Medical School talks to amfAR’s Dr. Rowena Johnston about his team’s efforts to rapidly develop a safe and effective vaccine against the coronavirus.